CD8+ T cells (cytotoxic T lymphocytes) can directly kill targeted tumor cells, while CD4+ T cells (helper T cells) play an important role in adaptive immune regulation and are key in tumor immunotherapy. This evidence concerns the gene CD8A and neoplasm.